IRF8 and renal carcinoma: Our data showed that IRF8 performed as a candidate tumor suppressor by inducing G2/M phase cell cycle arrest and apoptosis in MDA-MB-231 and T47D cells, consistent with the function of IRF8 in renal cancer [28], and also by inhibiting cell migration and invasion in MDA-MB-231, but not in T47D cells.